Theseus Pharmaceuticals Inc (DELISTED) (THRX:DL)
4.06
0.00 (0.00%)
USD |
NASDAQ |
Feb 23, 16:00
Theseus Pharmaceuticals EPS Diluted (Quarterly): -0.31 for Sept. 30, 2023
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | -0.31 |
| June 30, 2023 | -0.34 |
| March 31, 2023 | -0.34 |
| December 31, 2022 | -0.35 |
| September 30, 2022 | -0.38 |
| June 30, 2022 | -0.30 |
| March 31, 2022 | -0.27 |
| Date | Value |
|---|---|
| December 31, 2021 | -0.24 |
| September 30, 2021 | -0.2056 |
| June 30, 2021 | -0.1898 |
| March 31, 2021 | -0.1763 |
| December 31, 2020 | -0.1139 |
| September 30, 2020 | -0.0563 |
Earnings per Share Definition
Earnings per share measures the total net income / average shares outstanding during income period. There are a few variations to earnings per share that are listed including "EPS Basic", "EPS Diluted", "Normalized Basic EPS", and "Normalized Diluted EPS". Each of these metrics are dependent on which earnings and shares outstanding metrics are used. Basic and Diluted EPS differ in that diluted shares are the amount of shares outstanding after all convertible securities, options, and warrants are exercised. Normalized EPS allows does not include one-time expenses.
EPS Diluted (Quarterly) Range, Past 5 Years
-0.38
Minimum
Sep 2022
-0.0563
Maximum
Sep 2020
-0.2517
Average
-0.27
Median
Mar 2022
EPS Diluted (Quarterly) Benchmarks
| Karuna Therapeutics Inc (DELISTED) | -3.01 |
| NovaBay Pharmaceuticals Inc | -0.60 |
| Palatin Technologies Inc | -0.49 |
| iBio Inc | -0.9019 |
| Theriva Biologics Inc | -10.75 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -13.50M |
| Total Expenses (Quarterly) | 16.40M |